Connect with us

Heartland

Curaleaf Q2 Revenue Increases 22% sequentially to $117.5 million

Curaleaf Reports Record Second Quarter 2020 Financial and Operational Results Record Second Quarter Pro Forma Revenue(1)(2)of $165.4 Million and Record Second Quarter Managed Revenue(1)of $121.4 Million; Record First Half Managed Revenue(1) of $226.4 Million; Record Adjusted EBITDA(1) of $28.0 Million as Operations Across 17 States Continue to Scale; Completed Closing of the Grassroots Acquisition Expanding Presence to 23 States WAKEFIELD, Mass., Aug. 17, […]

Republished by Plato

Published

on

Curaleaf Reports Record Second Quarter 2020 Financial and Operational Results
  • Record Second Quarter Pro Forma Revenue(1)(2)of $165.4 Million and Record Second Quarter Managed Revenue(1)of $121.4 Million;
  • Record First Half Managed Revenue(1) of $226.4 Million;
  • Record Adjusted EBITDA(1) of $28.0 Million as Operations Across 17 States Continue to Scale;
  • Completed Closing of the Grassroots Acquisition Expanding Presence to 23 States

WAKEFIELD, Mass., Aug. 17, 2020 /PRNewswire/ — Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) (“Curaleaf” or the “Company”), a leading vertically integrated cannabis operator in the U.S., today reported its financial and operating results for the second quarter ended June 30, 2020. All financial information is provided in U.S. dollars unless otherwise indicated.

Second Quarter Highlights

  • Record managed revenue of $121.4 million, which grew 120% year-over-year and 16% sequentially, despite estimated $25.6 million revenue related impact from COVID-19 largely in Nevada and Massachusetts
  • Record total revenue of $117.5 million, which grew 142% year-over-year and 22% sequentially
  • Record Adjusted EBITDA of $28.0 million, which grew more than five times 2019 levels and 40% sequentially
  • Generated cash flow from operations of $23.4 million
  • Select launched into 2 new states
  • Completed acquisition of Arrow in Connecticut
  • Completed acquisition of Maine Remedy assets that were previously managed

Post Second Quarter Highlights

  • Completed acquisition of Grassroots creating the world’s largest cannabis Company
  • Completed acquisition of Curaleaf NJ, Inc. and Maine Organic Therapy assets that were previously managed
  • Closed acquisition of Blue Kudu enabling further roll-out of Select products in Colorado
  • Select launched into 4 new states; now available in 12 states
  • Completed a private placement of approximately $24.5 million in net proceeds
  • Raised approximately $42.0 million in net proceeds related to sale/leaseback transactions

Joseph Lusardi, Chief Executive Officer of Curaleaf stated “Curaleaf, once again, delivered record quarterly results highlighted by managed revenues exceeding our outlook, as well as, a 40% sequential improvement in Adjusted EBITDA. The outstanding results come despite headwinds related to temporary COVID-19 related closures and restrictions in Massachusetts and Nevada. After quarter end, we successfully completed the transformative acquisition of Grassroots, expanding our presence into 6 new states, including the high-growth Illinois and Pennsylvania markets.”

The closing of Grassroots affirms our position as the world’s largest cannabis company when measured by both revenue and operating presence. Overall, Curaleaf remains well positioned for continued growth in the second half of 2020.

Joseph Lusardi, Chief Executive Officer of Curaleaf

This growth will be driven by organic initiatives, the integrations of the Select and Grassroots businesses, as well as, the closing of multiple strategic tuck-in acquisitions across a number of key states.

Mike Carlotti, Chief Financial Officer of Curaleaf, added “Our top-line growth drove record adjusted EBITDA and an improved adjusted EBITDA margin. The strength of our balance sheet has allowed us to invest in our base business and opportunistically pursue additional strategic acquisitions. Looking forward, we anticipate a continued rise in managed revenue and adjusted EBITDA leading to strong sequential growth in the third quarter and second half of 2020 driven by organic growth, continued investment in key states, as well as, the integration of Select, Grassroots, Arrow and BlueKudu into our portfolio. Finally, we continue to make progress in converting and consolidating our managed entities in MaineNew Jersey and Massachusetts. As of today, we have consolidated all of our managed entities except for ATG which we expect to consolidate in the third quarter.”

Financial Results for the Second Quarter Ended June 30, 2020

Managed Revenue for the second quarter of 2020 was a record $121.4 million, an increase of 120% compared to $55.1 million in the second quarter of 2019. Managed Revenue for the second quarter increased 16% sequentially.

Total Revenue for the second quarter of 2020 was a record $117.5 million, an increase of 142% compared to $48.5 million in the second quarter of 2019. Total Revenue for the second quarter of 2020 increased 22% sequentially.

Retail revenue increased by 112% to $66.3 million during second the quarter of 2020, compared to $31.3 million in the second quarter of 2019. Growth in retail revenue was primarily due to organic growth and new store openings in FloridaMassachusetts and New York, impact of the Select acquisition, as well as, the acquisitions of three dispensaries in Arizona, two dispensaries in Nevada and from Maryland due to the addition of the HMS/MI businesses and Elevate Takoma, offset partially by the unforeseen negative impact of COVID-19 in Massachusetts and Nevada.

Wholesale revenue increased by 422% to $33.3 million during the second quarter of 2020, compared to $6.4 million in the second quarter of 2019. Growth in wholesale revenue was due primarily to the addition of Select.

Management fee income increased by 66% to $17.9 million during the second quarter of 2020, compared to $10.8 million in the second quarter of 2019. Growth in management fee income was due primarily to growth in New Jersey and management fees generated from Alternative Therapies Group (“ATG”) in Massachusetts.

Gross profit before impact of biological assets for the second quarter of 2020 was $60.6 million, compared to $26.0 million for the second quarter of 2019. The increase was primarily due to the continued improvement in the operating capacity and efficiency of the Company’s cultivation and processing facilities.

Gross profit on cannabis sales was $42.7 million for the second quarter of 2020, resulting in a 43% margin, compared to $15.3 million in the second quarter of 2019. The increase was primarily due to the continued improvement in the operating capacity and efficiency of the Company’s cultivation and processing facilities.

Adjusted EBITDA was a record $28.0 million for the second quarter of 2020, compared to $4.4 million for the second quarter of 2019.

Net loss for the second quarter of 2020 was $2.0 million, compared to a net loss of $24.5 million in the second quarter of 2019. The increase was primarily driven by a $19.2 million increase in the fair value of biological assets and a $1.1 million decrease in one-time charges. These benefits were partially offset by a $9.5 million increase in depreciation and amortization and a $0.3 million increase in share-based compensation, both of which are non-cash, a $5.3 million increase in income tax expense, and a $7.0 million increase in net interest expense.

Balance Sheet and Liquidity

As of June 30, 2020, we had $122.8 million of cash, $283.3 million of outstanding debt net of unamortized debt discounts and 533.2 million fully diluted shares outstanding.

Conference Call and Webcast Information

Curaleaf will host a conference call and audio webcast today at 5:00 pm ET to answer questions about the Company’s operational and financial highlights. The dial-in numbers for the conference call are +1-888-317-6003 (U.S.), +1-866-284-3684 (Canada) or +1-412-317-6061 (Int’l) Passcode: 0446838. Please dial-in 10 to 15 minutes prior to the start time of the conference call and an operator will register your name and organization.

The conference call will also be available via webcast, which can be accessed through the Investor Relations section of Curaleaf’s website, https://ir.curaleaf.com/events.

For interested individuals unable to join the conference call, a dial-in replay of the call will be available until August 24, 2020 at 11:59 pm ET and can be accessed by dialing +1-877-344-7529 (U.S.), +1-855-669-9658 (Canada) or +1-412-317-0088 (International) and entering replay pin number: 10146052. The online archive of the webcast will be available on https://ir.curaleaf.com/events for 90 days following the call.

Non-IFRS Financial and Performance Measures

In this press release Curaleaf refers to certain non-IFRS financial measures such as “Pro Forma Revenue”, “Managed Revenue”, “Gross Profit on Cannabis Sales” and “Adjusted EBITDA”. These measures do not have any standardized meaning prescribed by IFRS and may not be comparable to similar measures presented by other issuers. Curaleaf defines “Managed Revenue” as total revenue plus revenue from entities for which the Company has a management contract but does not consolidate the financial results based on IFRS 10 – Consolidated Financial Statements. Curaleaf defines “Pro Forma Revenue” as “Managed Revenue” plus revenue from operations of pending and closed acquisitions as if such acquisitions occurred on April 1, 2020. The Company defines “Gross Profit on Cannabis Sales” as retail and wholesale revenues less cost of goods sold. “Adjusted EBITDA” is defined by Curaleaf as earnings before interest, taxes, depreciation and amortization less share-based compensation expense and one-time charges related to business development, acquisition, financing and reorganization costs. Curaleaf considers these measures to be an important indicator of the financial strength and performance of our business. We believe the adjusted results presented provide relevant and useful information for investors because they clarify our actual operating performance, make it easier to compare our results with those of other companies and allow investors to review performance in the same way as our management. Since these measures are not calculated in accordance with IFRS, they should not be considered in isolation of, or as a substitute for, our reported results as indicators of our performance, and they may not be comparable to similarly named measures from other companies. The following tables provide a reconciliation of each of the non-IFRS measures to its closest IFRS measure.

About Curaleaf Holdings

Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) (“Curaleaf”) is the leading vertically integrated U.S. multi-state cannabis operator with a mission to improve lives by providing clarity around cannabis and confidence around consumption. As a high-growth cannabis company known for quality, expertise and reliability, the company and its brands, including Curaleaf and Select, provide industry-leading service, product selection and accessibility across the medical and adult-use markets. Curaleaf currently operates in 23 states with 87 dispensaries, 22 cultivation sites and over 30 processing sites, and employs over 3,000 team members across the United States. Curaleaf is listed on the Canadian Securities Exchange under the symbol CURA and trades on the OTCQX market under the symbol CURLF. For more information please visit www.curaleaf.com.

Original press release

Get ahead of the crowd by signing up for 420 Investor, the largest & most comprehensive premium subscription service for cannabis traders and investors since 2013.

Published by NCV Newswire
NCV Newswire
The NCV Newswire by New Cannabis Ventures aims to curate high quality content and information about leading cannabis companies to help our readers filter out the noise and to stay on top of the most important cannabis business news. The NCV Newswire is hand-curated by an editor and not automated in anyway. Have a confidential news tip? Get in touch.


Get Our Sunday Newsletter


Source: https://www.newcannabisventures.com/curaleaf-q2-revenue-increases-22-sequentially-to-117-5-million/

Heartland

Man shot in CBD overnight, NOPD says, as recent trend of gunfire downtown continues

Republished by Plato

Published

on

New Orleans police report a man was shot in the city’s Central Business District late Sunday night.

The unidentified man, police say, heard gunfire near the intersection of O’Keefe and Union streets just after 11 p.m. and realized he was shot.

The victim was reportedly driven to a hospital in a private vehicle.

No other information was released.

The shooting is the latest in a string of shootings in the city’s CBD. Those incidents include the following:

A man was shot in the 700 block of Canal on Oct. 17.

Four people were shot in the 100 block of Camp Street on Oct 2.

A man was shot in the 100 block of Camp Street on Sept. 26.

— A man was shot dead in the 1500 block of Canal Street on Sept. 10.

Lymon Brignac, 37, was shot dead near the corner of Canal Street and St. Charles Avenue on Sept. 8

In September, New Orleans surpassed the total number of homicides for all of 2019 with almost four months still left in the year. 

Source: https://www.google.com/url?rct=j&sa=t&url=https://www.nola.com/news/crime_police/article_1b1d5c76-174b-11eb-ad09-4bb475ed04b9.html&ct=ga&cd=CAIyGjQ2MzM1ZTBkNWQyZmIyYzc6Y29tOmVuOlVT&usg=AFQjCNF_ig8EmzwL8yeFXX2MYex8ZLti2A

Continue Reading

Heartland

Post Covid-19 Impact on CBD Hemp Oil Market Trend 2020-2027 by Top Regions- Cannoid …

Republished by Plato

Published

on

Indispensable insights of the CBD Hemp Oil Market are elaborated in the report. The core objective of the report is to deliver reliable and concrete information about the CBD Hemp Oil Market that can assist the businessmen to make rational decisions. The expected CAGR and valuation of the CBD Hemp Oil Market are mentioned in the report. Proficient analysts have studied the market for the evaluation year of 2020 to 2027. Significant factors that are likely to promote the growth of the CBD Hemp Oil Market and possible constraints of the CBD Hemp Oil Market are elaborated in the CBD Hemp Oil Market report. Potential growth scopes are also elaborated in the report.

The major vendors covered: Cannoid, Elixinol, Folium Biosciences, Gaia Botanicals, Canopy Growth Corporation, PharmaHemp, ENDOCA, Medical Marijuana, NuLeaf Naturals, CBD American Shaman, Aphria Inc., Isodiol, Aurora Cannabis, and more…

Get a free sample copy @ https://www.datalibraryresearch.com/sample-request/cbd-hemp-oil-market-350?utm_source=aerospace-journal&utm_medium=39

The CBD Hemp Oil Market studied in segments to provide information about the CBD Hemp Oil Market that encompasses crucial aspects of the CBD Hemp Oil Market. The regional progress of the CBD Hemp Oil Market is studied under the regional outlook section. A lucid understanding of the transforming competitive landscape of the CBD Hemp Oil Market can assist investors in several ways.  North America, Europe, and APAC are key regions across which the CBD Hemp Oil Market is studied. For the Rest of the World (RoW), the CBD Hemp Oil Market is analyzed across Latin America, South America, andthe Middle East Asia and Africa.

Key Players

Credible sources, such as surveys, financial magazines, and whitepapers are referred for listing. However, interviews with well-known personalities, such as CEOs, COO, and entrepreneurs are accepted as the most effective tool to prepare contribution of key players towards the growth of the CBD Hemp Oil Market. Past aspects and current trends of market players in the CBD Hemp Oil Market are elaborated in the report. The financial status of market players and their contributions are discussed in the report that offers a clear understanding to the investors and aids them in making rational decisions.

Research Methodology                                                                    

Research methodologies utilized in cooking the report are rigorous and fail-safe. The robust scoring process is employed to deliver an objective and accurate overview of the CBD Hemp Oil Market. Modern research techniques used to offer vivid qualitative and qualitative findings of the CBD Hemp Oil Market. The powerful research techniques used to study the CBD Hemp Oil Market aid in the collection of evidence and data to deliver precise report. The market research firm uses various tools for the collection of information for primary and secondary analysis of the CBD Hemp Oil Market to prepare a report that can be an ultimate guide for investors. Top-down and bottom-up approaches maintained for the assessment of the CBD Hemp Oil Market for the forecast years ensures high-quality and valuable insights into the CBD Hemp Oil Market.

If you have any special requirements about CBD Hemp Oil Market report, please let us know and we can provide custom report.

Inquire more about this report @ https://www.datalibraryresearch.com/enquiry/cbd-hemp-oil-market-350?utm_source=aerospace-journal&utm_medium=39

About Us:

Data Library Research is a market research company that helps to find its passion for helping brands grow, discover, and transform. We want our client to make wholehearted and long term business decisions. Data Library Research is committed to deliver their output from market research studies which are based on fact-based and relevant research across the globe. We offer premier market research services that cover all industries verticals, including agro-space defense, agriculture, and food, automotive, basic material, consumer, energy, life science, manufacturing, service, telecom, education, security, technology. We make sure that we make an honest attempt to provide clients an objective strategic insight, which will ultimately result in excellent outcomes.

Contact Us:

Alex Pandit,
Senior Manager International Sales and Marketing
Data Library Research
[email protected]
Ph: +13523530818 (US)
www.datalibraryresearch.com

Source: https://www.google.com/url?rct=j&sa=t&url=https://aerospace-journal.com/uncategorized/197260/post-covid-19-impact-on-cbd-hemp-oil-market-trend-2020-2027-by-top-regions-cannoid-elixinol-folium-biosciences-gaia-botanicals-canopy-growth-corporation-pharmahemp-endoca/&ct=ga&cd=CAIyGjQ2MzM1ZTBkNWQyZmIyYzc6Y29tOmVuOlVT&usg=AFQjCNECsxnJ2aBPlhG6xJwcbHazxOXTUA

Continue Reading

Heartland

Global CBD Plant Nutrients Market 2020 – Key Players, Region, Size, Share, Analysis With …

Republished by Plato

Published

on

Market research is one of the methods for the determination and estimation of the growth of the Global CBD Plant Nutrients Market in the estimated forecast period. In addition, it is also beneficial and used for the estimation of the several aspects of the market which are likely to have an impact on the growth and the forecast of the market in the estimated forecast period for the chemical industry.

This study covers following key players:
Company I
Company II
Company III

Request a sample of this report @ https://www.orbisresearch.com/contacts/request-sample/4942132?utm_source=Ulhas

The Global report on the Global CBD Plant Nutrients Market covers several aspects which are likely to have an impact on the growth of the market in the estimated forecast period. Moreover, it also determines and estimates several factors such as the drivers, challenges which are likely to have an impact on the growth of the market in the estimated forecast period. Moreover, it also uses and determines the strategies which are likely to have an impact on the growth of the market in the estimated forecast period. Moreover, increased demand for the estimation and accuracy among the customers is likely to affect the Global CBD Plant Nutrients Market strategy. It uses several methods which are likely used for the estimation and determination of the market forecast period.

Access Complete Report @ https://www.orbisresearch.com/reports/index/2020-market-research-report-on-global-cbd-plant-nutrients-industry?utm_source=Ulhas

Market segment by Type, the product can be split into
Type I
Type II
Type III

Market segment by Application, split into
Application I
Application II
Application III

One of the other strategy which is widely used in the market research study is the SWOT analysis. It is one of the most widely used strategy which is likely to have an impact on the growth of the market. Moreover, in this strategy, a detailed analysis of the strengths and the weakness of the Global ‘CBD Plant Nutrients’ market is covered and analyzed which is likely to impact the growth of the market in the estimated forecast period. Moreover, increased demand for the estimation of the segmental analysis is also used to predict the growth of the Global CBD Plant Nutrients Market. In addition, it also involves in forming the scope of the study of the research reports.  It also provides the estimated growth of the companies, along the recent strategies which is likely to impact the growth of the chemical market. The companies are known to have mergers and acquisitions which has a major impact, which is also one of the key aspects for the Global CBD Plant Nutrients and the other market. Furthermore, this strategy is also used to analyze the effect on the growth of the company which is likely to have an impact on the overall growth of the market in the estimated forecast period.

Moreover, increased demand for the estimation of the segmental analysis is also used to predict the growth of the Global CBD Plant Nutrients Market. In addition, it also involves in forming the scope of the study of the research reports.

For Enquiry before buying report @ https://www.orbisresearch.com/contacts/enquiry-before-buying/4942132?utm_source=Ulhas

About Us:
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.

Contact Us:
Hector Costello

Senior Manager Client Engagements

4144N Central Expressway,

Suite 600, Dallas,

Texas 75204, U.S.A.

Phone No.: USA: +1 (972)-362-8199 | IND: +91 895 659 5155

Source: https://www.google.com/url?rct=j&sa=t&url=https://technoweekly.com/uncategorized/492378/global-cbd-plant-nutrients-market-2020-key-players-region-size-share-analysis-with-forecast-2026/&ct=ga&cd=CAIyGjQ2MzM1ZTBkNWQyZmIyYzc6Y29tOmVuOlVT&usg=AFQjCNE8cw6Ssg8rUOq2MwSyLcH4mVgTNg

Continue Reading
Manufacturing5 days ago

New and Noteworthy Categories on Thomasnet.com for October 2020

Heartland5 days ago

Medical Marijuana: 7 Incredible Health Benefits for Women

Heartland5 days ago

CBG Study Shows Antimicrobial Properties of Cannabis

Heartland4 days ago

German Cannabis Flower Market is Ready to Explode

Heartland5 days ago

Thanks to these CBD “cigarettes” I am a full week tobacco/nicotine free 🎉

Heartland2 days ago

Medical Experts Discuss Uses of CBD (via JAMA — Top Medical Journal)

Heartland3 days ago

Dosage for CBG/CBD tincture from LN?

Heartland5 days ago

Will I get high from a gummy with 4.5 mg cbd and .5 mg thc? I have no tolerance.

Heartland4 days ago

Question on CBD vs CBG

Heartland4 days ago

Cybin Raises C$45 Million: The Largest Go Public Capital Raise in the Canadian Psychedelic Sector

Heartland4 days ago

Indus Holdings, Inc. Welcomes Bruce Gates to Board of Directors; Announces Results of Annual Shareholder Meeting

Heartland5 days ago

National Cannabis Lobbying Falls, Again

Heartland4 days ago

Europe CBD Oil Market 2020 | Covid19 Impact Analysis | Business Outlook, Growth, Revenue …

Heartland2 days ago

Is There An Age Limit For CBD? [Is It 18 or 21?]

Heartland5 days ago

In need of some honest advice/opinions concerning the use of thc as a maladaptive coping mechanism and the use of cbd to combat it

CBD2 days ago

CBD News Roundup: NFLPA Warns Players Not to Endorse CBD

Heartland4 days ago

Any success stories with smoking cessation?

Heartland4 days ago

How To Make CBD-Infused Face Masks At Home

Heartland4 days ago

Anyone begin CBD as a skeptic?

Heartland3 days ago

Mind Cure Announces LOI for Acquisition of Epiphany360 Digital Therapeutics Platform for Treating Mental Health

Heartland2 days ago

CBD is a life-saver for me.

Heartland24 hours ago

Terping out my own cbd/cbg isolate for dabbing!! YUM!

Heartland4 days ago

BZA denies permit for hemp facility on Poplar

News3 days ago

Report Finds Legal Cannabis Could Bring Texas $500M In Annual Tax Revenue

News5 days ago

The First Medical Cannabis Dispensary in Virginia has Opened its Doors

Heartland4 days ago

The Daily Hit: October 21, 2020

Heartland4 days ago

CBD Storefront 'The Green Room' Comes To Red Bank

Heartland3 days ago

Goal of industrial hemp is to augment existing food security planning

Heartland2 days ago

Industrial hemp seminar held in Chamberlain

Material4 days ago

Microstructure and mechanical properties of 34CrNiMo6 steel repaired by laser remelting

Trending

A Cloud Nine Capital Entity Copyright © 2020 – All Rights Reserved Proudly Made in America